NCT05000255 is a NA clinical trial of Intervention 1: According to DGP in Loneliness, sponsored by Annette Reichardt, MD.

Who is sponsoring NCT05000255?

NCT05000255 is sponsored by Annette Reichardt, MD.

What drugs are being tested in NCT05000255?

Interventions in NCT05000255: Intervention 1: According to DGP, Intervention 2: According to Cacioppo "E.A.S.E.".

What condition does NCT05000255 study?

NCT05000255 studies Loneliness, Depression, Anxiety, Self Efficacy, Social Support, Covid19, Psychology.

Is NCT05000255 still recruiting?

NCT05000255 is currently status unknown. Last updated 11 August 2021.

Last reviewed 2021-08-11 · How we verify

NCT05000255

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coping With Covid-19: Loneliness, Self-Efficacy, Social Support, Depression & Anxiety in Patients in Medical Rehab.

Status unknown NA Last updated 11 August 2021

What this trial tests

NA trial testing Intervention 1: According to DGP in Loneliness in 300 participants. Status unknown.

Timeline

18 January 2021

Primary endpoint
30 June 2022

30 September 2025

Quick facts

Lead sponsor	Annette Reichardt, MD
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	300
Start date	18 January 2021
Primary completion	30 June 2022
Estimated completion	30 September 2025
Sites	2 locations across Germany

Drugs / interventions tested

Intervention 1: According to DGP
Intervention 2: According to Cacioppo "E.A.S.E."

Conditions studied

Loneliness — all drugs for Loneliness →
Depression, Anxiety — all drugs for Depression, Anxiety →
Self Efficacy — all drugs for Self Efficacy →
Social Support — all drugs for Social Support →

Sponsor

Annette Reichardt, MD

Who can join

18 and older, any sex, with Loneliness or Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study is to investigate possible predictors and factors that may be associated with the development and maintenance of mental and physical health constrains including depression and anxiety symptomatology as well as loneliness in hospitalized post-COVID patients and non-COVID patients in Germany. Furthermore, it will be investigated whether psychological interventions have an effect on anxiety and depression symptomatology, on loneliness values, self-efficacy and perceived social support values. Specifically, the research aim is to examine the relationships between loneliness, self-efficacy, and social support and to address the question of what factors increase the risk of post covid depression/anxiety, and to test the buffering effect of physical and social activities. For this purpose an experimental group comparison will be applied, in which two interventions will be performed on post-COVID patients and non-COVID patients in the unit of Physical Medicine and Geriatrics in Medical Rehabilitation. (PhD Project by Annika Roskoschinski, M.Sc., Psychology, Principal Investigator)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Loneliness

Currently open trials in the same condition.

NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
NCT07443813 — An Innovative App-based Intervention to Promote Social Connectedness and Well-being in Older Adults · NA · active not recruiting
NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
NCT07107906 — Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Lone · NA · recruiting
NCT06919094 — A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05000255 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Annette Reichardt, MD
Last refreshed: 11 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05000255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing